The Role of the Rho/ROCK Pathway in Ang II and TGF-β1-Induced Atrial Remodeling
To study the role of the Rho/ROCK pathway in Ang II and TGF-β1-induced atrial remodeling. A canine atrial fibrillation (AF) model was established by rapid atrial pacing (RAP) of the left atrium. The roles of TGF-β1, the RhoA/ROCK signaling pathway and connective tissue growth factor (CTGF) in atrial...
Saved in:
| Published in | PloS one Vol. 11; no. 9; p. e0161625 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
01.09.2016
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | To study the role of the Rho/ROCK pathway in Ang II and TGF-β1-induced atrial remodeling.
A canine atrial fibrillation (AF) model was established by rapid atrial pacing (RAP) of the left atrium. The roles of TGF-β1, the RhoA/ROCK signaling pathway and connective tissue growth factor (CTGF) in atrial remodeling were studied via both in vitro and in vivo experiments. Each of the dogs that received RAP developed persistent AF within 4 weeks. The mRNA expression levels of TGF-β1 (1.32±0.38), Collagen-I(1.33±0.91), CTGF(5.83±3.71), RhoA(1.23±0.57) and ROCK-1 (1.02±0.27) in the left atrium were significantly increased following 4 weeks of RAP. Angiotensin II (Ang II) induced the proliferation of atrial fibroblasts and up-regulated the expression of both CTGF and ROCK-1 in a dose-dependent manner. Simvastatin and Y27632 reversed Ang II-induced CFs proliferation, as well as ROCK-1(0.89±0.05 and 1.27±0.03, respectively) and CTGF (0.87±0.04 and 0.91±0.02, respectively) expression. The expression mRNA of ROCK-1(1.74±0.13) and CTGF (2.28±0.11) can upregulated by TGF-β1, and down-regulated by Simvastatin (1.22±0.03 vs 2.27±0.11), Y27632 (1.01±0.04 vs 1.64±0.03), Los (1.04±0.11 vs 1.26±0.05), respectively. Losartan and Simvastatin attenuated the effects of TGF-β1, inhibited RhoA activity as opposed to RhoA protein expression. Y27632 had no effect on either the expression or the activity of RhoA.
The increased expression of profibrotic factors (CTGF, ROCK1 and Smad2/3) played an important role in our RAP-induced AF model. Increased atrial profibrotic factors involve the activation of either the TGF-β1/RhoA/ROCK-1 or the TGF-β1/Smad2/3 signaling pathway. |
|---|---|
| AbstractList | To study the role of the Rho/ROCK pathway in Ang II and TGF-β1-induced atrial remodeling.A canine atrial fibrillation (AF) model was established by rapid atrial pacing (RAP) of the left atrium. The roles of TGF-β1, the RhoA/ROCK signaling pathway and connective tissue growth factor (CTGF) in atrial remodeling were studied via both in vitro and in vivo experiments. Each of the dogs that received RAP developed persistent AF within 4 weeks. The mRNA expression levels of TGF-β1 (1.32±0.38), Collagen-I(1.33±0.91), CTGF(5.83±3.71), RhoA(1.23±0.57) and ROCK-1 (1.02±0.27) in the left atrium were significantly increased following 4 weeks of RAP. Angiotensin II (Ang II) induced the proliferation of atrial fibroblasts and up-regulated the expression of both CTGF and ROCK-1 in a dose-dependent manner. Simvastatin and Y27632 reversed Ang II-induced CFs proliferation, as well as ROCK-1(0.89±0.05 and 1.27±0.03, respectively) and CTGF (0.87±0.04 and 0.91±0.02, respectively) expression. The expression mRNA of ROCK-1(1.74±0.13) and CTGF (2.28±0.11) can upregulated by TGF-β1, and down-regulated by Simvastatin (1.22±0.03 vs 2.27±0.11), Y27632 (1.01±0.04 vs 1.64±0.03), Los (1.04±0.11 vs 1.26±0.05), respectively. Losartan and Simvastatin attenuated the effects of TGF-β1, inhibited RhoA activity as opposed to RhoA protein expression. Y27632 had no effect on either the expression or the activity of RhoA.The increased expression of profibrotic factors (CTGF, ROCK1 and Smad2/3) played an important role in our RAP-induced AF model. Increased atrial profibrotic factors involve the activation of either the TGF-β1/RhoA/ROCK-1 or the TGF-β1/Smad2/3 signaling pathway. Objectives To study the role of the Rho/ROCK pathway in Ang II and TGF-β1-induced atrial remodeling. Methods and Results A canine atrial fibrillation (AF) model was established by rapid atrial pacing (RAP) of the left atrium. The roles of TGF-β1, the RhoA/ROCK signaling pathway and connective tissue growth factor (CTGF) in atrial remodeling were studied via both in vitro and in vivo experiments. Each of the dogs that received RAP developed persistent AF within 4 weeks. The mRNA expression levels of TGF-β1 (1.32±0.38), Collagen-I(1.33±0.91), CTGF(5.83±3.71), RhoA(1.23±0.57) and ROCK-1 (1.02±0.27) in the left atrium were significantly increased following 4 weeks of RAP. Angiotensin II (Ang II) induced the proliferation of atrial fibroblasts and up-regulated the expression of both CTGF and ROCK-1 in a dose-dependent manner. Simvastatin and Y27632 reversed Ang II-induced CFs proliferation, as well as ROCK-1(0.89±0.05 and 1.27±0.03, respectively) and CTGF (0.87±0.04 and 0.91±0.02, respectively) expression. The expression mRNA of ROCK-1(1.74±0.13) and CTGF (2.28±0.11) can upregulated by TGF-β1, and down-regulated by Simvastatin (1.22±0.03 vs 2.27±0.11), Y27632 (1.01±0.04 vs 1.64±0.03), Los (1.04±0.11 vs 1.26±0.05), respectively. Losartan and Simvastatin attenuated the effects of TGF-β1, inhibited RhoA activity as opposed to RhoA protein expression. Y27632 had no effect on either the expression or the activity of RhoA. Conclusions The increased expression of profibrotic factors (CTGF, ROCK1 and Smad2/3) played an important role in our RAP-induced AF model. Increased atrial profibrotic factors involve the activation of either the TGF-β1/RhoA/ROCK-1 or the TGF-β1/Smad2/3 signaling pathway. To study the role of the Rho/ROCK pathway in Ang II and TGF-β1-induced atrial remodeling.OBJECTIVESTo study the role of the Rho/ROCK pathway in Ang II and TGF-β1-induced atrial remodeling.A canine atrial fibrillation (AF) model was established by rapid atrial pacing (RAP) of the left atrium. The roles of TGF-β1, the RhoA/ROCK signaling pathway and connective tissue growth factor (CTGF) in atrial remodeling were studied via both in vitro and in vivo experiments. Each of the dogs that received RAP developed persistent AF within 4 weeks. The mRNA expression levels of TGF-β1 (1.32±0.38), Collagen-I(1.33±0.91), CTGF(5.83±3.71), RhoA(1.23±0.57) and ROCK-1 (1.02±0.27) in the left atrium were significantly increased following 4 weeks of RAP. Angiotensin II (Ang II) induced the proliferation of atrial fibroblasts and up-regulated the expression of both CTGF and ROCK-1 in a dose-dependent manner. Simvastatin and Y27632 reversed Ang II-induced CFs proliferation, as well as ROCK-1(0.89±0.05 and 1.27±0.03, respectively) and CTGF (0.87±0.04 and 0.91±0.02, respectively) expression. The expression mRNA of ROCK-1(1.74±0.13) and CTGF (2.28±0.11) can upregulated by TGF-β1, and down-regulated by Simvastatin (1.22±0.03 vs 2.27±0.11), Y27632 (1.01±0.04 vs 1.64±0.03), Los (1.04±0.11 vs 1.26±0.05), respectively. Losartan and Simvastatin attenuated the effects of TGF-β1, inhibited RhoA activity as opposed to RhoA protein expression. Y27632 had no effect on either the expression or the activity of RhoA.METHODS AND RESULTSA canine atrial fibrillation (AF) model was established by rapid atrial pacing (RAP) of the left atrium. The roles of TGF-β1, the RhoA/ROCK signaling pathway and connective tissue growth factor (CTGF) in atrial remodeling were studied via both in vitro and in vivo experiments. Each of the dogs that received RAP developed persistent AF within 4 weeks. The mRNA expression levels of TGF-β1 (1.32±0.38), Collagen-I(1.33±0.91), CTGF(5.83±3.71), RhoA(1.23±0.57) and ROCK-1 (1.02±0.27) in the left atrium were significantly increased following 4 weeks of RAP. Angiotensin II (Ang II) induced the proliferation of atrial fibroblasts and up-regulated the expression of both CTGF and ROCK-1 in a dose-dependent manner. Simvastatin and Y27632 reversed Ang II-induced CFs proliferation, as well as ROCK-1(0.89±0.05 and 1.27±0.03, respectively) and CTGF (0.87±0.04 and 0.91±0.02, respectively) expression. The expression mRNA of ROCK-1(1.74±0.13) and CTGF (2.28±0.11) can upregulated by TGF-β1, and down-regulated by Simvastatin (1.22±0.03 vs 2.27±0.11), Y27632 (1.01±0.04 vs 1.64±0.03), Los (1.04±0.11 vs 1.26±0.05), respectively. Losartan and Simvastatin attenuated the effects of TGF-β1, inhibited RhoA activity as opposed to RhoA protein expression. Y27632 had no effect on either the expression or the activity of RhoA.The increased expression of profibrotic factors (CTGF, ROCK1 and Smad2/3) played an important role in our RAP-induced AF model. Increased atrial profibrotic factors involve the activation of either the TGF-β1/RhoA/ROCK-1 or the TGF-β1/Smad2/3 signaling pathway.CONCLUSIONSThe increased expression of profibrotic factors (CTGF, ROCK1 and Smad2/3) played an important role in our RAP-induced AF model. Increased atrial profibrotic factors involve the activation of either the TGF-β1/RhoA/ROCK-1 or the TGF-β1/Smad2/3 signaling pathway. Objectives To study the role of the Rho/ROCK pathway in Ang II and TGF-β1-induced atrial remodeling. Methods and Results A canine atrial fibrillation (AF) model was established by rapid atrial pacing (RAP) of the left atrium. The roles of TGF-β1, the RhoA/ROCK signaling pathway and connective tissue growth factor (CTGF) in atrial remodeling were studied via both in vitro and in vivo experiments. Each of the dogs that received RAP developed persistent AF within 4 weeks. The mRNA expression levels of TGF-β1 (1.32±0.38), Collagen-I(1.33±0.91), CTGF(5.83±3.71), RhoA(1.23±0.57) and ROCK-1 (1.02±0.27) in the left atrium were significantly increased following 4 weeks of RAP. Angiotensin II (Ang II) induced the proliferation of atrial fibroblasts and up-regulated the expression of both CTGF and ROCK-1 in a dose-dependent manner. Simvastatin and Y27632 reversed Ang II-induced CFs proliferation, as well as ROCK-1(0.89±0.05 and 1.27±0.03, respectively) and CTGF (0.87±0.04 and 0.91±0.02, respectively) expression. The expression mRNA of ROCK-1(1.74±0.13) and CTGF (2.28±0.11) can upregulated by TGF-β1, and down-regulated by Simvastatin (1.22±0.03 vs 2.27±0.11), Y27632 (1.01±0.04 vs 1.64±0.03), Los (1.04±0.11 vs 1.26±0.05), respectively. Losartan and Simvastatin attenuated the effects of TGF-β1, inhibited RhoA activity as opposed to RhoA protein expression. Y27632 had no effect on either the expression or the activity of RhoA. Conclusions The increased expression of profibrotic factors (CTGF, ROCK1 and Smad2/3) played an important role in our RAP-induced AF model. Increased atrial profibrotic factors involve the activation of either the TGF-β1/RhoA/ROCK-1 or the TGF-β1/Smad2/3 signaling pathway. To study the role of the Rho/ROCK pathway in Ang II and TGF-β1-induced atrial remodeling. A canine atrial fibrillation (AF) model was established by rapid atrial pacing (RAP) of the left atrium. The roles of TGF-β1, the RhoA/ROCK signaling pathway and connective tissue growth factor (CTGF) in atrial remodeling were studied via both in vitro and in vivo experiments. Each of the dogs that received RAP developed persistent AF within 4 weeks. The mRNA expression levels of TGF-β1 (1.32±0.38), Collagen-I(1.33±0.91), CTGF(5.83±3.71), RhoA(1.23±0.57) and ROCK-1 (1.02±0.27) in the left atrium were significantly increased following 4 weeks of RAP. Angiotensin II (Ang II) induced the proliferation of atrial fibroblasts and up-regulated the expression of both CTGF and ROCK-1 in a dose-dependent manner. Simvastatin and Y27632 reversed Ang II-induced CFs proliferation, as well as ROCK-1(0.89±0.05 and 1.27±0.03, respectively) and CTGF (0.87±0.04 and 0.91±0.02, respectively) expression. The expression mRNA of ROCK-1(1.74±0.13) and CTGF (2.28±0.11) can upregulated by TGF-β1, and down-regulated by Simvastatin (1.22±0.03 vs 2.27±0.11), Y27632 (1.01±0.04 vs 1.64±0.03), Los (1.04±0.11 vs 1.26±0.05), respectively. Losartan and Simvastatin attenuated the effects of TGF-β1, inhibited RhoA activity as opposed to RhoA protein expression. Y27632 had no effect on either the expression or the activity of RhoA. The increased expression of profibrotic factors (CTGF, ROCK1 and Smad2/3) played an important role in our RAP-induced AF model. Increased atrial profibrotic factors involve the activation of either the TGF-β1/RhoA/ROCK-1 or the TGF-β1/Smad2/3 signaling pathway. |
| Author | Xu, Cheng-Gui Xu, Zhe Wu, Su-Hua Cheng, Yun-Jiu Lu, Gui-Hua Liu, Li-Juan Tang, Kai Yao, Feng-Juan Gao, Xiu-Ren |
| AuthorAffiliation | Department of Cardiology and Department of Ultrasonography (Feng-Juan Yao), the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China University at Buffalo - The State University of New York, UNITED STATES |
| AuthorAffiliation_xml | – name: University at Buffalo - The State University of New York, UNITED STATES – name: Department of Cardiology and Department of Ultrasonography (Feng-Juan Yao), the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China |
| Author_xml | – sequence: 1 givenname: Li-Juan surname: Liu fullname: Liu, Li-Juan – sequence: 2 givenname: Feng-Juan surname: Yao fullname: Yao, Feng-Juan – sequence: 3 givenname: Gui-Hua surname: Lu fullname: Lu, Gui-Hua – sequence: 4 givenname: Cheng-Gui surname: Xu fullname: Xu, Cheng-Gui – sequence: 5 givenname: Zhe surname: Xu fullname: Xu, Zhe – sequence: 6 givenname: Kai surname: Tang fullname: Tang, Kai – sequence: 7 givenname: Yun-Jiu surname: Cheng fullname: Cheng, Yun-Jiu – sequence: 8 givenname: Xiu-Ren surname: Gao fullname: Gao, Xiu-Ren – sequence: 9 givenname: Su-Hua surname: Wu fullname: Wu, Su-Hua |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27611832$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kt1u0zAUxyM0xD7gDRBY4mY36fwdh4tJVbWNikmbqnJtObHdunLt4iSgvRYPwjORrCnaJsSVj875n9_52z6n2VGIwWTZewQniBToYhO7FJSf7Pr0BCKOOGavshNUEpxzDMnRk_g4O22aDYSMCM7fZMe44AgJgk-y--XagEX0BkQL2iFex4vF3ewruFft-qd6AC6AaViB-RyooMHy5jr__Qvl86C72mgwbZNTHizMNmrjXVi9zV5b5RvzbjzPsm_XV8vZl_z27mY-m97mNaWI5aZE2pYaUlIhY6FVTAlmVWGIUGUpCNeKliU2pFLUMEE1KhgnlbG6gpXgkJxlH_fcnY-NHB-jkUggAWmJCesV871CR7WRu-S2Kj3IqJx8TMS0kiq1rvZGYogtLWss-iGU9Q5qDguKLLKW11qJnnU5TuuqrdG1CW1S_hn0eSW4tVzFH5LB3ngxAM5HQIrfO9O0cuua2nivgondo-8SYcw56aWfXkj_fbsPTx39tXL42l7weS-oU2yaZKysXataFweDzksE5bBHB7gc9kiOe9Q30xfNB_5_2_4AIf3M-A |
| CitedBy_id | crossref_primary_10_3389_fphar_2021_734917 crossref_primary_10_1007_s10557_023_07447_y crossref_primary_10_1002_lary_31505 crossref_primary_10_1007_s10753_024_01996_6 crossref_primary_10_1159_000493692 crossref_primary_10_1155_2020_1358098 crossref_primary_10_3390_jcm9010165 crossref_primary_10_2174_1570180819666220512170331 crossref_primary_10_1080_08820139_2022_2027961 crossref_primary_10_3390_ijms22062839 crossref_primary_10_1002_jcb_27496 crossref_primary_10_3389_fimmu_2019_00784 crossref_primary_10_3390_ijms21155398 crossref_primary_10_1093_bjd_ljae384 crossref_primary_10_1177_1559325820968413 crossref_primary_10_3390_physiologia3010004 crossref_primary_10_1007_s00424_021_02514_5 crossref_primary_10_1093_europace_euaa009 crossref_primary_10_1080_21691401_2019_1637885 crossref_primary_10_1080_14728222_2020_1712593 |
| Cites_doi | 10.1253/circj.CJ-10-0892 10.1016/j.ejphar.2008.12.049 10.1161/CIRCULATIONAHA.105.584623 10.1369/jhc.4A6560.2005 10.1016/j.biocel.2012.12.016 10.1056/NEJM199809033391003 10.1126/science.275.5304.1308 10.1016/j.ejphar.2008.03.006 10.1161/01.STR.22.8.983 10.1038/359693a0 10.1016/j.cardiores.2003.11.032 10.1096/fj.05-5129com 10.1172/JCI6842 10.1006/jmcc.1998.0799 10.1161/CIRCRESAHA.110.234369 10.1111/wrr.12136 10.2174/156652409787847164 10.1006/meth.2001.1262 10.1161/01.CIR.82.3.792 10.1001/jama.1994.03510350050036 10.1136/bmj.330.7485.238 10.1093/ndt/gfr012 10.1016/j.autneu.2011.01.004 10.1038/aps.2011.54 10.1016/j.ejphar.2005.02.024 10.1016/j.yjmcc.2015.03.004 10.1681/ASN.V1291853 10.1161/01.CIR.96.4.1180 10.1111/j.1540-8159.1997.tb06199.x 10.1136/gut.2004.051169 10.3892/etm.2014.2143 10.1006/jmcc.2000.1215 10.3727/095535491820873191 10.1042/BJ20130744 10.1016/S0735-1097(03)00464-9 10.1152/ajplung.00443.2005 10.1038/ncb826 10.1161/CIRCULATIONAHA.105.613083 10.1161/01.RES.86.5.571 |
| ContentType | Journal Article |
| Copyright | 2016 Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2016 Liu et al 2016 Liu et al |
| Copyright_xml | – notice: 2016 Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2016 Liu et al 2016 Liu et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0161625 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts ProQuest Nursing and Allied Health Journals - PSU access expires 11/30/25. Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium ProQuest advanced technologies & aerospace journals ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Agricultural Science Database MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) |
| DocumentTitleAlternate | Rho/ROCK Pathway in Atrial Remodeling |
| EISSN | 1932-6203 |
| ExternalDocumentID | 1818049235 oai_doaj_org_article_202f49c28756458a9c60741f1ff6cda8 PMC5017578 4176851691 27611832 10_1371_journal_pone_0161625 |
| Genre | Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM CGR CUY CVF ECM EIF IPNFZ NPM PJZUB PPXIY PQGLB RIG 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PKEHL PQEST PQUKI PRINS RC3 7X8 5PM PUEGO - 02 AAPBV ABPTK ADACO BBAFP BBORY KM |
| ID | FETCH-LOGICAL-c4415-e91df9d043b1ef0fa5a85fa7e38a99836da4992e3ba4e584d17563befdb0b8603 |
| IEDL.DBID | M48 |
| ISSN | 1932-6203 |
| IngestDate | Sun May 01 00:10:51 EDT 2022 Wed Aug 27 01:03:38 EDT 2025 Thu Aug 21 18:32:34 EDT 2025 Fri Jul 11 04:09:53 EDT 2025 Fri Jul 25 10:40:57 EDT 2025 Mon Jul 21 06:00:05 EDT 2025 Tue Jul 01 01:56:08 EDT 2025 Thu Apr 24 23:11:11 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9 |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4415-e91df9d043b1ef0fa5a85fa7e38a99836da4992e3ba4e584d17563befdb0b8603 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: The authors have declared that no competing interests exist. Conceived and designed the experiments: LL XG SW.Performed the experiments: LL FY GL CX ZX KT YC.Analyzed the data: LL FY GL CX ZX KT YC XG SW.Contributed reagents/materials/analysis tools: LL FY GL CX ZX KT YC.Wrote the paper: LL FY GL CX ZX KT YC XG SW. |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0161625 |
| PMID | 27611832 |
| PQID | 1818049235 |
| PQPubID | 1436336 |
| ParticipantIDs | plos_journals_1818049235 doaj_primary_oai_doaj_org_article_202f49c28756458a9c60741f1ff6cda8 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5017578 proquest_miscellaneous_1819122663 proquest_journals_1818049235 pubmed_primary_27611832 crossref_citationtrail_10_1371_journal_pone_0161625 crossref_primary_10_1371_journal_pone_0161625 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2016-09-01 |
| PublicationDateYYYYMMDD | 2016-09-01 |
| PublicationDate_xml | – month: 09 year: 2016 text: 2016-09-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2016 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | VP Sah (ref39) 1999; 103 AJ Sanfilippo (ref25) 1990; 82 X Gao (ref8) 2009; 606 YM Zhang (ref30) 2006; 20 JH Mun (ref34) 2014; 22 H Nakajima (ref10) 2000; 86 Y Rikitake (ref20) 2005; 112 KE Porter (ref27) 2004; 61 YX Wang (ref31) 2005; 512 X He (ref17) 2011; 108 RG Dean (ref14) 2005; 53 MB Iqbal (ref5) 2005; 330 MM Shull (ref11) 1992; 359 MM Chen (ref13) 2000; 32 K Kumagai (ref16) 2003; 41 Z Huang (ref33) 2006; 290 KJ Livak (ref22) 2001; 25 Y Zhai (ref7) 2008; 587 YH Yeh (ref9) 2015; 82 WC Ko (ref15) 2011; 75 N Washida (ref19) 2011; 26 H Zhou (ref26) 2011; 32 B Cui (ref21) 2011; 161 M Haissaguerre (ref3) 1998; 339 A Ames (ref4) 2006; 113 P Gervaz (ref36) 2009; 9 Y Cui (ref18) 2015; 9 JG Abreu (ref37) 2002; 4 J Heusinger-Ribeiro (ref32) 2001; 12 EJ Benjamin (ref1) 1994; 271 MS Spach (ref24) 1997; 20 M Amano (ref28) 1997; 275 H Ohnishi (ref12) 1998; 30 J Yang (ref29) 2013; 45 A Frustaci (ref6) 1997; 96 SJ Lee (ref38) 2013; 456 C Bourgier (ref35) 2005; 54 PA Wolf (ref2) 1991; 22 AH Cory (ref23) 1991; 3 15677659 - BMJ. 2005 Jan 29;330(7485):238-43 25574246 - Exp Ther Med. 2015 Feb;9(2):631-635 11518778 - J Am Soc Nephrol. 2001 Sep;12(9):1853-61 12821247 - J Am Coll Cardiol. 2003 Jun 18;41(12):2197-204 9286947 - Circulation. 1997 Aug 19;96(4):1180-4 8114238 - JAMA. 1994 Mar 16;271(11):840-4 10377168 - J Clin Invest. 1999 Jun;103(12):1627-34 21378147 - Nephrol Dial Transplant. 2011 Sep;26(9):2770-9 21576830 - Circ J. 2011;75(7):1592-600 19374881 - Eur J Pharmacol. 2009 Mar 15;606(1-3):115-20 11846609 - Methods. 2001 Dec;25(4):402-8 19355909 - Curr Mol Med. 2009 Apr;9(3):273-80 21316313 - Auton Neurosci. 2011 Apr 26;161(1-2):87-94 16585395 - Circulation. 2006 Apr 4;113(13):e666-8 1867954 - Cancer Commun. 1991 Jul;3(7):207-12 21743486 - Acta Pharmacol Sin. 2011 Aug;32(8):999-1008 15710979 - Gut. 2005 Mar;54(3):336-43 9725923 - N Engl J Med. 1998 Sep 3;339(10):659-66 2144217 - Circulation. 1990 Sep;82(3):792-7 1866765 - Stroke. 1991 Aug;22(8):983-8 12134160 - Nat Cell Biol. 2002 Aug;4(8):599-604 15956033 - J Histochem Cytochem. 2005 Oct;53(10):1245-56 16260635 - Circulation. 2005 Nov 8;112(19):2959-65 24471776 - Wound Repair Regen. 2014 Jan-Feb;22(1):125-33 9036856 - Science. 1997 Feb 28;275(5304):1308-11 10720419 - Circ Res. 2000 Mar 17;86(5):571-9 23277274 - Int J Biochem Cell Biol. 2013 Mar;45(3):657-66 14985071 - Cardiovasc Res. 2004 Mar 1;61(4):745-55 23988089 - Biochem J. 2013 Nov 15;456(1):109-18 1436033 - Nature. 1992 Oct 22;359(6397):693-9 25771143 - J Mol Cell Cardiol. 2015 May;82:84-92 9925376 - J Mol Cell Cardiol. 1998 Nov;30(11):2411-22 9058844 - Pacing Clin Electrophysiol. 1997 Feb;20(2 Pt 2):397-413 11013125 - J Mol Cell Cardiol. 2000 Oct;32(10):1805-19 15840407 - Eur J Pharmacol. 2005 Apr 11;512(2-3):215-22 16675849 - FASEB J. 2006 May;20(7):916-25 21127293 - Circ Res. 2011 Jan 21;108(2):164-75 18430418 - Eur J Pharmacol. 2008 Jun 10;587(1-3):196-203 16684954 - Am J Physiol Lung Cell Mol Physiol. 2006 Jun;290(6):L1291-9 |
| References_xml | – volume: 75 start-page: 1592 year: 2011 ident: ref15 article-title: Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes publication-title: Circ J doi: 10.1253/circj.CJ-10-0892 – volume: 606 start-page: 115 year: 2009 ident: ref8 article-title: Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2008.12.049 – volume: 112 start-page: 2959 year: 2005 ident: ref20 article-title: Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient mice publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.105.584623 – volume: 53 start-page: 1245 year: 2005 ident: ref14 article-title: Connective tissue growth factor and cardiac fibrosis after myocardial infarction publication-title: J Histochem Cytochem doi: 10.1369/jhc.4A6560.2005 – volume: 45 start-page: 657 year: 2013 ident: ref29 article-title: Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo publication-title: Int J Biochem Cell Biol doi: 10.1016/j.biocel.2012.12.016 – volume: 339 start-page: 659 year: 1998 ident: ref3 article-title: Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins publication-title: N Engl J Med doi: 10.1056/NEJM199809033391003 – volume: 275 start-page: 1308 year: 1997 ident: ref28 article-title: Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase publication-title: Science doi: 10.1126/science.275.5304.1308 – volume: 587 start-page: 196 year: 2008 ident: ref7 article-title: Fluvastatin decreases cardiac fibrosis possibly through regulation of TGF-beta(1)/Smad 7 expression in the spontaneously hypertensive rats publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2008.03.006 – volume: 22 start-page: 983 year: 1991 ident: ref2 article-title: Atrial fibrillation as an independent risk factor for stroke: the Framingham Study publication-title: Stroke doi: 10.1161/01.STR.22.8.983 – volume: 359 start-page: 693 year: 1992 ident: ref11 article-title: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease publication-title: Nature doi: 10.1038/359693a0 – volume: 61 start-page: 745 year: 2004 ident: ref27 article-title: Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA publication-title: Cardiovasc Res doi: 10.1016/j.cardiores.2003.11.032 – volume: 20 start-page: 916 year: 2006 ident: ref30 article-title: Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis publication-title: FASEB J doi: 10.1096/fj.05-5129com – volume: 103 start-page: 1627 year: 1999 ident: ref39 article-title: Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure publication-title: J Clin Invest doi: 10.1172/JCI6842 – volume: 30 start-page: 2411 year: 1998 ident: ref12 article-title: Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats publication-title: J Mol Cell Cardiol doi: 10.1006/jmcc.1998.0799 – volume: 108 start-page: 164 year: 2011 ident: ref17 article-title: Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.110.234369 – volume: 22 start-page: 125 year: 2014 ident: ref34 article-title: Simvastatin inhibits transforming growth factor-beta1-induced expression of type I collagen, CTGF, and alpha-SMA in keloid fibroblasts publication-title: Wound Repair Regen doi: 10.1111/wrr.12136 – volume: 9 start-page: 273 year: 2009 ident: ref36 article-title: Molecular aspects of intestinal radiation-induced fibrosis publication-title: Curr Mol Med doi: 10.2174/156652409787847164 – volume: 25 start-page: 402 year: 2001 ident: ref22 article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method publication-title: Methods doi: 10.1006/meth.2001.1262 – volume: 82 start-page: 792 year: 1990 ident: ref25 article-title: Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study publication-title: Circulation doi: 10.1161/01.CIR.82.3.792 – volume: 271 start-page: 840 year: 1994 ident: ref1 article-title: Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study publication-title: JAMA doi: 10.1001/jama.1994.03510350050036 – volume: 330 start-page: 238 year: 2005 ident: ref5 article-title: Recent developments in atrial fibrillation publication-title: BMJ doi: 10.1136/bmj.330.7485.238 – volume: 26 start-page: 2770 year: 2011 ident: ref19 article-title: Rho-kinase inhibition ameliorates peritoneal fibrosis and angiogenesis in a rat model of peritoneal sclerosis publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfr012 – volume: 161 start-page: 87 year: 2011 ident: ref21 article-title: Acute effects of ganglionated plexi ablation on sinoatrial nodal and atrioventricular nodal functions publication-title: Auton Neurosci doi: 10.1016/j.autneu.2011.01.004 – volume: 32 start-page: 999 year: 2011 ident: ref26 article-title: Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes publication-title: Acta Pharmacol Sin doi: 10.1038/aps.2011.54 – volume: 512 start-page: 215 year: 2005 ident: ref31 article-title: Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2005.02.024 – volume: 82 start-page: 84 year: 2015 ident: ref9 article-title: Rosuvastatin suppresses atrial tachycardia-induced cellular remodeling via Akt/Nrf2/heme oxygenase-1 pathway publication-title: J Mol Cell Cardiol doi: 10.1016/j.yjmcc.2015.03.004 – volume: 12 start-page: 1853 year: 2001 ident: ref32 article-title: Expression of connective tissue growth factor in human renal fibroblasts: regulatory roles of RhoA and cAMP publication-title: J Am Soc Nephrol doi: 10.1681/ASN.V1291853 – volume: 96 start-page: 1180 year: 1997 ident: ref6 article-title: Histological substrate of atrial biopsies in patients with lone atrial fibrillation publication-title: Circulation doi: 10.1161/01.CIR.96.4.1180 – volume: 20 start-page: 397 year: 1997 ident: ref24 article-title: Microfibrosis produces electrical load variations due to loss of side-to-side cell connections: a major mechanism of structural heart disease arrhythmias publication-title: Pacing Clin Electrophysiol doi: 10.1111/j.1540-8159.1997.tb06199.x – volume: 54 start-page: 336 year: 2005 ident: ref35 article-title: Inhibition of Rho kinase modulates radiation induced fibrogenic phenotype in intestinal smooth muscle cells through alteration of the cytoskeleton and connective tissue growth factor expression publication-title: Gut doi: 10.1136/gut.2004.051169 – volume: 9 start-page: 631 year: 2015 ident: ref18 article-title: Effect of valsartan on atrial fibrillation recurrence following pulmonary vein isolation in patients publication-title: Exp Ther Med doi: 10.3892/etm.2014.2143 – volume: 32 start-page: 1805 year: 2000 ident: ref13 article-title: CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis publication-title: J Mol Cell Cardiol doi: 10.1006/jmcc.2000.1215 – volume: 3 start-page: 207 year: 1991 ident: ref23 article-title: Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture publication-title: Cancer Commun doi: 10.3727/095535491820873191 – volume: 456 start-page: 109 year: 2013 ident: ref38 article-title: PKCdelta as a regulator for TGF-beta-stimulated connective tissue growth factor production in human hepatocarcinoma (HepG2) cells publication-title: Biochem J doi: 10.1042/BJ20130744 – volume: 41 start-page: 2197 year: 2003 ident: ref16 article-title: Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(03)00464-9 – volume: 290 start-page: L1291 year: 2006 ident: ref33 article-title: Modulation by bradykinin of angiotensin type 1 receptor-evoked RhoA activation of connective tissue growth factor expression in human lung fibroblasts publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00443.2005 – volume: 4 start-page: 599 year: 2002 ident: ref37 article-title: Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta publication-title: Nat Cell Biol doi: 10.1038/ncb826 – volume: 113 start-page: e666 year: 2006 ident: ref4 article-title: Cardiology patient page. Catheter ablation of atrial fibrillation publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.105.613083 – volume: 86 start-page: 571 year: 2000 ident: ref10 article-title: Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart publication-title: Circ Res doi: 10.1161/01.RES.86.5.571 – reference: 10720419 - Circ Res. 2000 Mar 17;86(5):571-9 – reference: 15840407 - Eur J Pharmacol. 2005 Apr 11;512(2-3):215-22 – reference: 9058844 - Pacing Clin Electrophysiol. 1997 Feb;20(2 Pt 2):397-413 – reference: 21743486 - Acta Pharmacol Sin. 2011 Aug;32(8):999-1008 – reference: 16585395 - Circulation. 2006 Apr 4;113(13):e666-8 – reference: 10377168 - J Clin Invest. 1999 Jun;103(12):1627-34 – reference: 8114238 - JAMA. 1994 Mar 16;271(11):840-4 – reference: 16260635 - Circulation. 2005 Nov 8;112(19):2959-65 – reference: 11518778 - J Am Soc Nephrol. 2001 Sep;12(9):1853-61 – reference: 15956033 - J Histochem Cytochem. 2005 Oct;53(10):1245-56 – reference: 21576830 - Circ J. 2011;75(7):1592-600 – reference: 2144217 - Circulation. 1990 Sep;82(3):792-7 – reference: 1436033 - Nature. 1992 Oct 22;359(6397):693-9 – reference: 18430418 - Eur J Pharmacol. 2008 Jun 10;587(1-3):196-203 – reference: 11846609 - Methods. 2001 Dec;25(4):402-8 – reference: 9725923 - N Engl J Med. 1998 Sep 3;339(10):659-66 – reference: 16684954 - Am J Physiol Lung Cell Mol Physiol. 2006 Jun;290(6):L1291-9 – reference: 9036856 - Science. 1997 Feb 28;275(5304):1308-11 – reference: 19355909 - Curr Mol Med. 2009 Apr;9(3):273-80 – reference: 12821247 - J Am Coll Cardiol. 2003 Jun 18;41(12):2197-204 – reference: 9925376 - J Mol Cell Cardiol. 1998 Nov;30(11):2411-22 – reference: 11013125 - J Mol Cell Cardiol. 2000 Oct;32(10):1805-19 – reference: 1866765 - Stroke. 1991 Aug;22(8):983-8 – reference: 1867954 - Cancer Commun. 1991 Jul;3(7):207-12 – reference: 25771143 - J Mol Cell Cardiol. 2015 May;82:84-92 – reference: 23277274 - Int J Biochem Cell Biol. 2013 Mar;45(3):657-66 – reference: 16675849 - FASEB J. 2006 May;20(7):916-25 – reference: 24471776 - Wound Repair Regen. 2014 Jan-Feb;22(1):125-33 – reference: 15677659 - BMJ. 2005 Jan 29;330(7485):238-43 – reference: 23988089 - Biochem J. 2013 Nov 15;456(1):109-18 – reference: 21378147 - Nephrol Dial Transplant. 2011 Sep;26(9):2770-9 – reference: 15710979 - Gut. 2005 Mar;54(3):336-43 – reference: 19374881 - Eur J Pharmacol. 2009 Mar 15;606(1-3):115-20 – reference: 14985071 - Cardiovasc Res. 2004 Mar 1;61(4):745-55 – reference: 21316313 - Auton Neurosci. 2011 Apr 26;161(1-2):87-94 – reference: 25574246 - Exp Ther Med. 2015 Feb;9(2):631-635 – reference: 9286947 - Circulation. 1997 Aug 19;96(4):1180-4 – reference: 21127293 - Circ Res. 2011 Jan 21;108(2):164-75 – reference: 12134160 - Nat Cell Biol. 2002 Aug;4(8):599-604 |
| SSID | ssj0053866 |
| Score | 2.371877 |
| Snippet | To study the role of the Rho/ROCK pathway in Ang II and TGF-β1-induced atrial remodeling.
A canine atrial fibrillation (AF) model was established by rapid... Objectives To study the role of the Rho/ROCK pathway in Ang II and TGF-β1-induced atrial remodeling. Methods and Results A canine atrial fibrillation (AF)... To study the role of the Rho/ROCK pathway in Ang II and TGF-β1-induced atrial remodeling.OBJECTIVESTo study the role of the Rho/ROCK pathway in Ang II and... To study the role of the Rho/ROCK pathway in Ang II and TGF-β1-induced atrial remodeling.A canine atrial fibrillation (AF) model was established by rapid... Objectives To study the role of the Rho/ROCK pathway in Ang II and TGF-β1-induced atrial remodeling. Methods and Results A canine atrial fibrillation (AF)... |
| SourceID | plos doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e0161625 |
| SubjectTerms | Angiotensin Angiotensin II Angiotensin II - pharmacology Animals Atrial Fibrillation - metabolism Atrial Remodeling - drug effects Atrium Biology and life sciences Cardiac arrhythmia Cardiology Collagen Connective tissue growth factor Connective Tissue Growth Factor - genetics Connective Tissue Growth Factor - metabolism Connective tissues Disease Models, Animal Dogs Female Fibrillation Fibroblasts Gene expression Growth factors Kinases Male Medicine and Health Sciences Research and Analysis Methods rho GTP-Binding Proteins - genetics rho GTP-Binding Proteins - metabolism Rho-associated kinase rho-Associated Kinases - genetics rho-Associated Kinases - metabolism RhoA protein Rocks Science Signal transduction Signal Transduction - drug effects Signaling Simvastatin Smad2 protein Transforming Growth Factor beta1 - pharmacology Transforming growth factor-b1 Ultrasonic imaging |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1PT9swFLcmTrtM498IMGQkDnAwxHXiJMcOrcCmDVQViVtkxzatVCUVLUL7Wvsg-0x7z3GrFlXiwi2KncR5f_x-T7Z_j5CTzBnpso5h2i8zVi5mkKtIlmZKFlZUKja4ovvrt7y-T348pA9Lpb5wT1hLD9wKDpNzlxQVAHvkPclVUUmMgo47Jyuj_DFfiHnzZKqdg8GLpQwH5UTGL4JezidNbc8R5Egsjb0UiDxfP_KbjpvpOqz5esvkUgzqfSafAnik3XbQm-SDrbfIZnDPKT0NHNJn2-QO1E_7zdjSxtEZXg-bi_7t5U96B5DvRf2ho5p260d6c0NVbejgqsf-_eUMK3lU1tCur-ZB-9ZXyoHwtkPue98Hl9csFE9gFaZIzBbcuMLEidDcutipVOWpU5kVIMMiF9IoSHY6VmiVWEAhBnCEFNo6o2Ody1jsko0axLVHqFRcp8rFIPIk0ZrnLk0N8tRBdFcm4RERc0mWVWAWxwIX49Ivl2WQYbTyKVH-ZZB_RNjiqUnLrPFG_2-opEVf5MX2N8BaymAt5VvWEpE9VPH8A9OS41l3JKmD9x_O1b6--XjRDB6Iyyqqts2z71NwQLFSRORLayWLQXYyyXHSjEi2Yj8rf7HaUo-GnuU7hbkSptP99_jtA_IRgJ5s98Ydko3Z07P9CmBqpo-83_wH8hwcJA priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3NbtQwELagXLggyl_TFmQkDnBwN45jJzmhpWLbgoBq1Uq9RXZst5VWydLdquK1eBCeiRnHWbqogtsqdrTOjGfmm4zzDSFvCm-VLzLLTCgzNj5lkKsoJgutKicanVqs6H75qg5P809n8iy-cFvEY5WDTwyO2nYNviMfcfwoGdnE5Pv5d4Zdo7C6Glto3CcPOEQaPNJVTg4GTwy2rFT8XE4UfBS1szfvWreHUEdhg-xb4Siw9iPL6axb3IU4_z44eSsSTR6TRxFC0nGv801yz7VPyGY00gV9G5mk3z0lx7AJ6LSbOdp5usTfF91o-m3_Mz0G4Hejf9DLlo7bc3p0RHVr6cnBhP36yRn282icpePQ04NOXeiXA0HuGTmdfDzZP2SxhQJrMFFiruLWVzbNheHOp15LXUqvCydKDYmWUFZDypM5YXTuAItYQBNKGOetSU2pUvGcbLQgri1CleZGap9y7_PcGF56KS2y1UGM1zbnCRGDJOsm8otjm4tZHYpmBeQZvXxqlH8d5Z8Qtrpr3vNr_Gf-B1TSai6yY4cL3dV5HY2tztLM51UDySBy5cCTNgqRk4elq8bqMiFbqOLhDxb1n82VkN1B7XcPv14Ngx1icUW3rrsOcyoOWFaJhLzod8lqkVmhOLrOhBRr-2ftKdZH2suLwPUtwWOCU93-97J2yEMAcqo_-7ZLNpZX1-4lgKWleRUs4jf6oRQw priority: 102 providerName: ProQuest |
| Title | The Role of the Rho/ROCK Pathway in Ang II and TGF-β1-Induced Atrial Remodeling |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/27611832 https://www.proquest.com/docview/1818049235 https://www.proquest.com/docview/1819122663 https://pubmed.ncbi.nlm.nih.gov/PMC5017578 https://doaj.org/article/202f49c28756458a9c60741f1ff6cda8 http://dx.doi.org/10.1371/journal.pone.0161625 |
| Volume | 11 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLZ2eeEFMW7LNioj8QAPKXGc2MkDQl3VbgNtVNUq9S1yYnubVCWj7TT2wo_ih_CbOMdNIoqK4MWKYud27GN_Jyf5PkLeSKuFlaH2c5dmLGzgQ6wi_FgqkRpeqEBjRvf8QpxOok_TeLpFGs3W2oCLjaEd6klN5rPut68PH8HhPzjVBsmag7q3VWm6CGEA02-TXVibJGoanEdtXgG822UvEbX4Igx4_TPd386ytlg5Tn_kQJ1Vi0149M_PKn9bp4ZPyOMaYNLeakTskS1TPiV7tQsv6NuaZ_rdMzKCIULH1czQytIlbl9X78df-p_pCGDhvXqgNyXtlVf07IyqUtPLk6H_8wfzUe2jMJr2nOIHHRunpgNL4HMyGQ4u-6d-LbDgFxhG-SZl2qY6iHjOjA2silUSWyUNTxSEYVxoBQFRaHiuIgNIRQPWEDw3VudBnoiAvyA7JZhrn1ChWB4rGzBroyjPWWLjWCOXHSAApSPmEd5YMitq9nEUwZhlLqUmIQpZ2SdD-2e1_T3it0fdrtg3_tH-GDupbYvc2W5HNb_KalfMwiC0UVpAqIhMOvCkhUBcZeHWRaFV4pF97OLmAouM4f_wSGQH5z9qun1z9eu2GrwUUy-qNNWda5MyQLqCe-TlapS0NxlKwXBi9YhcGz9rT7FeU95cOybwGOZTmHIP_uO6h-QRYD2x-jzuiOws53fmFeCpZd4h23IqoUz6DMvhSYfsHg8uRuOOe0PRcS6E5ffBL44mJDo |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwED-N8QAvaOPfAgOMBBI8ZI3jxEkeECqDrqXbmKpO2ltwYnubVCXd2mnal-KBD8Jn4i5_yoomeNpbVLuNfT7f_a5n_w7gTWS1tJGv3axKM-bWczFWkW4YKZkYkStPU0Z3b1_2D4OvR-HRCvxo78LQscrWJlaGWpc5_Ufe4XQpmdjEwo_TM5eqRlF2tS2hUavF0FxdYsg2-zD4jOv71vd7X8bbfbepKuDmFDu4JuHaJtoLRMaN9awKVRxaFRkRK4w9hNQKowDfiEwFBt2zRgcrRWaszrwslp7A370DdwOBnpxupvd2WsuPtkPK5nqeiHin0YataVmYLYJWkgpyX3N_VZUAYlWdlLObEO7fBzWveb7eGjxoICvr1jq2DiumeAjrjVGYsXcNc_X7R3CASsdG5cSw0rI5PZ-UndG37SE7QKB5qa7YacG6xTEbDJgqNBvv9NxfP7lL9UNyo1m3qiHCRqaqz4NO9TEc3opwn8BqgeLaACYVz0JlPW5tEGQZj20YamLHQ0yhdMAdEK0k07zhM6eyGpO0StJFGNfU8klJ_mkjfwfcxbemNZ_Hf_p_okVa9CU27uqD8vw4bTZ36nu-DZIcg0_i5sGZ5pKQmsWhy1yr2IENWuL2BbP0jzI7sNku-83NrxfNuO8pmaMKU15UfRKO2FkKB57WWrIYpB9JTqbagWhJf5ZmsdxSnJ5U3OIhWmg04s_-PaxXcK8_3ttNdwf7w-dwH0GkrM_dbcLq_PzCvECgNs9eVruDwffb3o6_Af76UZo |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIiEuiPKqocAigQQHN16vvbYPCIWU0BAoUdRKvZm1d7etFNmhSVX1b3HkR_CbmPGLBlVw6s3KbuLd2Xl8k5mdAXgZWS1t5Gs3q8KMufVc9FWkG0ZKJkbkytMU0f2yJ3cPgk-H4eEa_GzvwlBaZasTK0Wty5z-I-9xupRM1cTCnm3SIiY7w3fz7y51kKJIa9tOo2aRsbk4R_dt8Xa0g2f9yveHH_YHu27TYcDNyY9wTcK1TbQXiIwb61kVqji0KjIiVuiHCKkVegS-EZkKDJpqjcZWisxYnXlZLD2Bv3sDbkYiiknG4kGXXoJ6RMrmqp6IeK_hjO15WZhtglmSmnNfMoVVxwCqsDorF1eh3b-TNi9ZweFduNPAV9av-W0D1kxxDzYaBbFgr5sq1m_uwwQZkE3LmWGlZUt6Pi5706-DMZsg6DxXF-ykYP3iiI1GTBWa7X8cur9-cJd6ieRGs37VT4RNTdWrBw3sAzi4FuI-hPUCybUJTCqehcp63NogyDIe2zDUVCkP8YXSAXdAtJRM86a2ObXYmKVVwC5CH6emT0r0Txv6O-B235rXtT3-M_89HVI3lypzVx-Up0dpI-ip7_k2SHJ0RKlOD-40l4TaLC5d5lrFDmzSEbcvWKR_GNuBrfbYrx5-0Q2jDqDAjipMeVbNSTjiaCkceFRzSbdIP5Kc1LYD0Qr_rOxidaQ4Oa7qjIeorVGhP_73sp7DLRTE9PNob_wEbiOelHUK3hasL0_PzFPEbMvsWSUcDL5dtzT-BjWuVZs |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Role+of+the+Rho%2FROCK+Pathway+in+Ang+II+and+TGF-%CE%B21-Induced+Atrial+Remodeling&rft.jtitle=PloS+one&rft.au=Liu%2C+Li-Juan&rft.au=Yao%2C+Feng-Juan&rft.au=Lu%2C+Gui-Hua&rft.au=Xu%2C+Cheng-Gui&rft.date=2016-09-01&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=11&rft.issue=9&rft.spage=e0161625&rft_id=info:doi/10.1371%2Fjournal.pone.0161625&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |